| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Neuro-Oncology Laboratory, Barrow Neurological Institute of St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013-4496
A unique characteristic of astrocytic malignancies is their frequent dissemination through the brain. Cellular determinants of migration include adhesion to the substratum, restructuring of the actin cytoskeleton to generate motion, and (in the setting of invasion into tissue) secretion of enzymes for remodeling interstitial space to accommodate forward motion of the migrating cell. In order to better understand these features in the context of local brain invasion by astrocytoma cells, the adhesion and migratory properties of these cells have been investigated in an in vitro monolayer system. Adhesion of 8 different astrocytoma cell lines to different purified human extracellular matrix (ECM) proteins (collagen type IV, cellular fibronectin, laminin, and vitronectin) revealed that there is no "astrocytoma-specific" ECM protein that consistently leads to high cell binding. Similarly, migration of astrocytoma cells was found to be variable and dependent on different ECM proteins. Laminin was frequently the most permissive for adhesion and migration. Adhesion to collagen, fibronectin, and vitronectin was integrin dependent and could be blocked using anti-ß1 integrin antibodies; in contrast, attachment to laminin could not be blocked using these antibodies. A comparison of adhesion with migration for each of the cell lines on each of the 4 ECM proteins revealed that poor adhesion was associated with minimal migration and that frequently, high adhesion was correlated with rapid migration. When tested for migration on autologous, cell-derived ECM, none of the cell lines were as migratory as they were on one of the purified ECM proteins, with the exception of SF767 cells. Furthermore, it was found that ECM from SF767 cells promoted the migration of other astrocytoma cells. The results from this study indicate that migration is a constitutive behavior of glioma cells which is dependent on, or modified by, the presence or absence of permissive ligands in the environment.
1 Supported by NIH Grant NS27030 (M. E. B., M. D. R.), Phi Beta Psi Sorority, and the Deutsche Forschungsgemeinschaft Grant Gi 218/1-2 (A. G.).
2 To whom requests for reprints should be addressed, at Neuro-Oncology Laboratory, Barrow Neurological Institute of St. Joseph's Hospital and Medical Center, 350 West Thomas Road, Phoenix, AZ 85013-4496.
Received 12/22/93. Accepted 5/12/94.
This article has been cited by other articles:
|
|
 |
|
  E. Delamarre, S. Taboubi, S. Mathieu, C. Berenguer, V. Rigot, J.-C. Lissitzky, D. Figarella-Branger, L. Ouafik, and J. Luis Expression of Integrin {alpha}6{beta}1 Enhances Tumorigenesis in Glioma Cells Am. J. Pathol., August 1, 2009; 175(2): 844 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Loftus, Z. Yang, N. L. Tran, J. Kloss, C. Viso, M. E. Berens, and C. A. Lipinski The Pyk2 FERM domain as a target to inhibit glioma migration Mol. Cancer Ther., June 1, 2009; 8(6): 1505 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bassi, S. Mello, R. Cardoso, P. Godoy, A. Fachin, C. Junta, P Sandrin-Garcia, C. Carlotti, R. Falcao, E. Donadi, et al. Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation Human and Experimental Toxicology, December 1, 2008; 27(12): 919 - 929. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Jarzynka, B. Hu, K.-M. Hui, I. Bar-Joseph, W. Gu, T. Hirose, L. B. Haney, K. S. Ravichandran, R. Nishikawa, and S.-Y. Cheng ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion Cancer Res., August 1, 2007; 67(15): 7203 - 7211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhu, V. M. Gokhale, L. Szabo, R. M. Munoz, H. Baek, S. Bashyam, L. H. Hurley, D. D. Von Hoff, and H. Han Identification of a novel inhibitor of urokinase-type plasminogen activator Mol. Cancer Ther., April 1, 2007; 6(4): 1348 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakada, K. L. Drake, S. Nakada, J. A. Niska, and M. E. Berens Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1. Cancer Res., September 1, 2006; 66(17): 8492 - 8500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kishi, S. Okudaira, M. Tanaka, K. Hama, D. Shida, J. Kitayama, T. Yamori, J. Aoki, T. Fujimaki, and H. Arai Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid J. Biol. Chem., June 23, 2006; 281(25): 17492 - 17500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Salhia, F. Rutten, M. Nakada, C. Beaudry, M. Berens, A. Kwan, and J. T. Rutka Inhibition of Rho-Kinase Affects Astrocytoma Morphology, Motility, and Invasion through Activation of Rac1 Cancer Res., October 1, 2005; 65(19): 8792 - 8800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakada, J. A. Niska, N. L. Tran, W. S. McDonough, and M. E. Berens EphB2/R-Ras Signaling Regulates Glioma Cell Adhesion, Growth, and Invasion Am. J. Pathol., August 1, 2005; 167(2): 565 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lefranc, J. Brotchi, and R. Kiss Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis J. Clin. Oncol., April 1, 2005; 23(10): 2411 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-y. Chuang, N. L. Tran, N. Rusk, M. Nakada, M. E. Berens, and M. Symons Role of Synaptojanin 2 in Glioma Cell Migration and Invasion Cancer Res., November 15, 2004; 64(22): 8271 - 8275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakada, J. A. Niska, H. Miyamori, W. S. McDonough, J. Wu, H. Sato, and M. E. Berens The Phosphorylation of EphB2 Receptor Regulates Migration and Invasion of Human Glioma Cells Cancer Res., May 1, 2004; 64(9): 3179 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Joy, C. E. Beaudry, N. L. Tran, F. A. Ponce, D. R. Holz, T. Demuth, and M. E. Berens Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis J. Cell Sci., November 1, 2003; 116(21): 4409 - 4417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Giese, R. Bjerkvig, M.E. Berens, and M. Westphal Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment J. Clin. Oncol., April 15, 2003; 21(8): 1624 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Tran, W. S. McDonough, P. J. Donohue, J. A. Winkles, T. J. Berens, K. R. Ross, D. B. Hoelzinger, C. Beaudry, S. W. Coons, and M. E. Berens The Human Fn14 Receptor Gene Is Up-Regulated in Migrating Glioma Cells in Vitro and Overexpressed in Advanced Glial Tumors Am. J. Pathol., April 1, 2003; 162(4): 1313 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Lipinski, N. L. Tran, C. Bay, J. Kloss, W. S. McDonough, C. Beaudry, M. E. Berens, and J. C. Loftus Differential Role of Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase in Determining Glioblastoma Migration and Proliferation Mol. Cancer Res., March 1, 2003; 1(5): 323 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Perego, C. Vanoni, S. Massari, A. Raimondi, S. Pola, M. G. Cattaneo, M. Francolini, L. M. Vicentini, and G. Pietrini Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system J. Cell Sci., August 15, 2002; 115(16): 3331 - 3340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Fenton, M. S. Wolff, M. W. Orth, and N. G. Hord Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype Carcinogenesis, June 1, 2002; 23(6): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mariani, C. Beaudry, W. S. McDonough, D. B. Hoelzinger, E. Kaczmarek, F. Ponce, S. W. Coons, A. Giese, R. W. Seiler, and M. E. Berens Death-associated Protein 3 (Dap-3) Is Overexpressed in Invasive Glioblastoma Cells in Vivo and in Glioma Cell Lines with Induced Motility Phenotype in Vitro Clin. Cancer Res., August 1, 2001; 7(8): 2480 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mariani, W. S. McDonough, D. B. Hoelzinger, C. Beaudry, E. Kaczmarek, S. W. Coons, A. Giese, M. Moghaddam, R. W. Seiler, and M. E. Berens Identification and Validation of P311 as a Glioblastoma Invasion Gene Using Laser Capture Microdissection Cancer Res., May 1, 2001; 61(10): 4190 - 4196. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Kruse, S. Visonneau, B. K. Kleinschmidt-DeMasters, C. J. Gup, G. G. Gomez, D. B. Paul, and D. Santoli The Human Leukemic T-Cell Line, TALL-104, Is Cytotoxic to Human Malignant Brain Tumors and Traffics through Brain Tissue: Implications for Local Adoptive Immunotherapy Cancer Res., October 1, 2000; 60(20): 5731 - 5739. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Soroceanu, T. J. Manning Jr, and H. Sontheimer Modulation of Glioma Cell Migration and Invasion Using Cl- and K+ Ion Channel Blockers J. Neurosci., July 15, 1999; 19(14): 5942 - 5954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Y. Gillespie, L. Soroceanu, T. J. Manning Jr., C. L. Gladson, and S. S. Rosenfeld Glioma Migration Can Be Blocked by Nontoxic Inhibitors of Myosin II Cancer Res., May 1, 1999; 59(9): 2076 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Giese, C. Hagel, E. L. Kim, S. Zapf, J. Djawaheri, M. E. Berens, and M. Westphal Thromboxane synthase regulates the migratory phenotype of human glioma cells Neuro-oncol, January 1, 1999; 1(1): 3 - 13. [Abstract] [PDF]
|
|
|
|
|
|
S. Sultana, R. Zhou, M. S. Sadagopan, and O. Skalli Effects of Growth Factors and Basement Membrane Proteins on the Phenotype of U-373 MG Glioblastoma Cells as Determined by the Expression of Intermediate Filament Proteins Am. J. Pathol., October 1, 1998; 153(4): 1157 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Phillips, L. Krushel, and K. Crossin Domains of tenascin involved in glioma migration J. Cell Sci., January 4, 1998; 111(8): 1095 - 1104. [Abstract] [PDF]
|
|
|
|
|
|
A Giese, M. Loo, S. Norman, S Treasurywala, and M. Berens Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins J. Cell Sci., January 8, 1996; 109(8): 2161 - 2168. [Abstract] [PDF]
|
|
|
|
|
|
C. Liu, J. Yao, D. Mercola, and E. Adamson The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251 J. Biol. Chem., June 30, 2000; 275(27): 20315 - 20323. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
